POLYMORPHONUCLEAR NEUTROPHIL (PMN) infiltration into the postischemic reperfused myocardium has previously (11) been implicated in the pathogenesis of ischemia-reperfusion injury. Production of reactive oxygen species and PMN degranulation, resulting in the release of proteolytic enzymes within the ischemic reperfused myocardium, may contribute to myocyte death and subsequent myocardial dysfunction (11) .
Reactive oxygen species, such as superoxide radical, hydrogen peroxide, and hydroxyl radical, have been implicated in the pathogenesis of ischemia-reperfusion injury in a variety of organs, including the brain (33) , large intestine (28) , and heart (14) . Numerous studies have quantified an increase in reactive oxygen species production following myocardial ischemia-reperfusion (9, 12, 19, 36) . A potential source of these reactive oxygen species is the respiratory burst production of superoxide radicals by NADPH oxidase of activated neutrophils. Xanthine oxidase and NADH/NADPH oxidase activity within endothelial cells is an additional source of toxic oxidants (10) . The highly reactive nature of reactive oxygen species can result in lethal damage to vital cell components resulting in loss of cell integrity and cellular necrosis (32) . Previous studies have shown that these deleterious effects are attenuated by the administration of toxic oxidant scavengers, such as superoxide dismutase and catalase (3, 14, 34) . Clearly, reactive oxygen species from one or multiple sources can contribute to the development of myocardial ischemia-reperfusion injury.
The recent isolation of a novel proline-arginine-rich antimicrobial peptide, PR-39, from pig intestine may aid in the investigation of myocardial ischemia-reperfusion injury (1) . PR-39 has bactericidal properties that are unique in that it kills by a non-pore-forming mechanism that inhibits DNA and protein synthesis in gram-positive and gram-negative bacteria (5) . Other effects of PR-39 include increased syndecan expression, a proteoglycan involved in wound repair (6) . Additionally, this peptide has also been shown to be a powerful inhibitor of neutrophilic NADPH oxidase activity by interacting with the p47 phox subunit (31). Furthermore, PR-39 has been shown to prevent neutrophil recruitment following ischemia and reperfusion possibly by downregulation of endothelial cell adhesion molecules (18) . The availability of synthetic PR-39 affords the opportunity to investigate the pathophysiological role of neutrophil recruitment in the development of myocardial ischemia-reperfusion injury.
Because of the potent antineutrophil action of PR-39, we hypothesized that this novel agent might attenuate myocardial ischemia-reperfusion injury and inhibit neutrophil-endothelial adherence within the microcirculation. To test this hypothesis, mice were subjected to acute coronary artery ligation and reperfusion following pretreatment with the peptide PR-39. In additional experiments, the recruitment of leukocytes to the inflamed mesentery following PR-39 treatment was assessed using intravital microscopy in rats.
MATERIALS AND METHODS
Peptide treatment. PR-39 was supplied by Dr. Chris Ross at Kansas State University College of Veterinary Medicine. The peptide was synthesized by solid-phase method, using t-butyloxycarbonyl chemistry as previously described (30) with greater than 90% purity.
Male SV129 mice, utilized for the myocardial ischemiareperfusion protocol, were injected with the PR-39 peptide (14 mg/kg, n ϭ 9) or saline vehicle (n ϭ 12) intravenously through the ventral tail vein 30 min prior to the surgical protocol. Male Sprague-Dawley rats utilized for intravital microscopy were superfused 30 min prior to data collection with either vehicle (n ϭ 7), 0.5 U/ml thrombin (n ϭ 6), or 250 g PR-39 ϩ 0.5 U/ml thrombin (n ϭ 7 Myocardial Ischemia: Reperfusion surgical procedure. Mice were allowed free access to normal rodent chow, exposed to 12:12-h light-dark cycles, and housed in a climatecontrolled room. The surgical protocol and infarct size determination were performed similar to methods described previously (16) with several modifications due to the longer period of reperfusion in the present study. Briefly, the mice were anesthetized with pentobarbital sodium (50 mg/kg ip) and ketamine (50 mg/kg ip). Through direct visualization, the mice were orally intubated with polyethylene (PE-90) tubing. The animals were then connected to a rodent ventilator (model 683, Harvard Apparatus). The left anterior descending coronary artery (LAD) was visualized and ligated with 7-0 silk suture (Ethicon). After 30 min of LAD occlusion, the ligature was carefully severed to allow for reperfusion. Reperfusion was visually confirmed. A small piece of 7-0 silk suture was left in the myocardium to ensure that the LAD was religated in the exact same location. The chest wall was closed with three interrupted sutures (4-0 silk), and the skin was approximated with a continuous suture (4-0 silk). The animals were given butorphanol tartrate (ϳ0.1 mg/kg ip) for analgesia. The animals were given supplemental 100% oxygen via a nasal cone and allowed to recover in a temperaturecontrolled area.
At the end of 24 h of reperfusion, the mice were anesthetized with pentobarbital sodium (50 mg/kg ip) and ketamine (50 mg/kg ip), a tracheostomy was performed, and the mouse was connected to the respirator. The right common carotid artery was cannulated for Evans blue dye infusion. The LAD was religated at the same location as the previous ligation, and Evans blue (1.5 ml of a 1.0% solution) was retrogradely infused into the carotid artery catheter to delineate the ischemic from the nonischemic zones. The heart was excised and cut in 1-mm-thick cross sections. Ex vivo incubation of the heart sections in 2,3,5-triphenyltetrazolium chloride for 5 min at 37°C allowed differentiation between the viable and necrotic areas of the myocardium previously rendered ischemic. Each slice was weighed and visualized under a dissecting microscope (model SZ4045, Olympus America) equipped with a Sony charge-couple device Iris color video camera (Sony Electronics). The left ventricular (LV) area, area-atrisk (AAR), and area of infarction (INF) for each slice were then determined by computer planimetry using NIH Image (version 1.57) software. The size of the myocardial infarction was determined by the following equation: weight of infarc-
, where A is percent area of infarction by planimetry from subscripted numbers 1-5 representing sections, and W is the weight of the same numbered section.
Myocardial histology. Routine histological staining was performed on multiple sections of midventricular cardiac sections to determine the extent of PMN infiltration within the ischemic reperfused zone. Mice were subjected to the myocardial ischemia-reperfusion protocol as described above. Midventricular tissue slices (1 mm in thickness) were prepared from hearts subjected to the myocardial ischemiareperfusion protocol. The tissue sections were immediately fixed and stored in a 10% neutral buffered Formalin solution (Sigma Diagnostics). The tissue slices were then embedded in paraffin and cut into 10-m sections and placed on slides. The tissue specimens were then stained with Gill no. 3 hematoxylin and eosin. The slides were then viewed microscopically, and the number of PMNs per high-power field was determined. For each of the hearts examined, the number of PMNs was counted in the ischemic reperfused zone (LV anterior wall) in six fields of three independent tissue sections by a blinded observer.
Intravital microscopy of rat mesenteric venules. SpragueDawley rats (200-250 g), anesthetized with pentobarbital sodium (50 mg/kg), were superfused with vehicle (n ϭ 7), 0.5 U/ml thrombin (n ϭ 6), or 250 g PR-39 ϩ 0.5 U/ml thrombin (n ϭ 7) 30 min prior to data collection. The abdominal cavity was opened via a midline laparotomy as described earlier (29) . Briefly, a loop of ileal mesentery was exteriorized through the midline incision and placed in a temperaturecontrolled superfusion chamber. The ileum and mesentery were superfused throughout the experiment with a modified Krebs-Henseleit solution (containing, in mM, 118 NaCl, 4.74 KCl, 2.45 CaCl 2 , 1.19 MgSO 4 , and 12.5 NaHCO 3 ), warmed to 37°C, and bubbled with 95% N 2 -5% CO 2 . A Microphoto microscope (Nikon, Tokyo, Japan) was used to visualize the mesenteric microcirculation and mesenteric tissue as previously described (29) . Red blood cell velocity was determined online using an optical Doppler velocimeter obtained from the Microcirculation Research Institute (College Station, TX). This method gives an average red blood cell velocity that can be digitally displayed on a meter and allows for calculation of shear rates. Red blood cell (rbc) velocity (V) and venular diameter (D) were used to calculate venular wall shear rate (g) employing the formula: g ϭ 8(V mean /D)(V mean ϭ V rbc /1.6) (29) .
Video recordings were made at 0, 10, 20, and 30 min after initiation of superfusion for quantification of leukocyte rolling and adherence. The number of rolling and adhered leukocytes was determined offline by playback analysis of the videotape as previously reported (29) . Leukocytes were considered to be rolling if they were moving at a velocity significantly slower than that of red blood cells. Leukocyte rolling is expressed as the number of cells moving past a designated point per minute. A leukocyte was judged to be adherent if it remained stationary for more than 30 s. Adherence is ex-pressed as the number of leukocytes adhering to the endothelium per 100 m of vessel length.
Statistical analysis. All findings were analyzed with a two-tailed unpaired t-test. All statistics were calculated with StatView 4.5 (Abacus Concepts). All values are reported as means Ϯ SE. Statistical significance was set at P Ͻ 0.05.
RESULTS

Myocardial AAR and infarct size.
Similarly sized AARs were observed in both vehicle (n ϭ 12) and PR-39 (n ϭ 9) mice. Vehicle mice (n ϭ 12) displayed an AAR per LV of 56.8 Ϯ 1.9%, and the AAR was similar in PR-39-treated hearts (56.3 Ϯ 2.7%). In contrast, the INF per AAR was significantly (P Ͻ 0.01) reduced by 55% in wild-type mice treated with PR-39 (21.0 Ϯ 3.8%) compared with vehicle (47.1 Ϯ 4.8%) (Fig. 1) . Additionally, INF per LV was 26.9 Ϯ 3.1% in the vehicle group, and this effect was significantly (P Ͻ 0.01) diminished with the administration of the PR-39 peptide (12.5 Ϯ 2.8%).
Myocardial PMN accumulation. Histological analysis of PMN accumulation within the ischemic reperfused myocardium of mice subjected to 30 min of coronary artery occlusion and 24 h of reperfusion is displayed in Fig. 2 . Mice administered PR-39 (n ϭ 6) prior to myocardial ischemia-reperfusion displayed a significant (P Ͻ 0.01) reduction of 57% in PMN infiltration (34.3 Ϯ 1.7 PMN/mm 2 ) compared with mice given a saline vehicle (n ϭ 6, 59.7 Ϯ 3.1 PMN/mm 2 ). Intravital microscopy. The effects of thrombin and thrombin ϩ PR-39 administration on leukocyte rolling are presented in Fig. 3 . Treatment with thrombin significantly (P Ͻ 0.05) increased leukocyte rolling within the rat mesentery compared with vehicle. Thrombinstimulated leukocyte rolling was significantly (P Ͻ 0.05) attenuated with the addition of PR-39 at all time points except baseline. The significance of this effect increased at the 90 and 120 min time points (P Ͻ 0.01).
Leukocyte adhesion following treatment with thrombin and thrombin ϩ PR-39 is presented in Fig. 4 . Thrombin treatment significantly (P Ͻ 0.05) increased leukocyte adhesion to the mesenteric venule endothelium at time points beyond 30 min compared with vehicle-treated rats. PR-39 significantly attenuated thrombin stimulation at 60 min (P Ͻ 0.05), 90 min (P Ͻ 0.01), and 120 min (P Ͻ 0.01).
DISCUSSION
In this study, we evaluated the effects of PR-39, an inhibitor of neutrophil recruitment as well as phagocyte NADPH oxidase, in the pathogenesis of myocardial ischemia and reperfusion injury in mice. Our results clearly indicate that PR-39 attenuated the development of myocardial infarction and diminishes 2 . Myocardial polymorphonuclear neutrophil (PMN) accumulation after 30 min of ischemia and 24 h of reperfusion in the ischemic reperfused areas of heart from PR-39-treated mice (n ϭ 6) and vehicle-treated mice (n ϭ 4). The number of PMNs per millimeters squared was determined in 4 fields for each heart. Myocardial PMN infiltration was significantly (P Ͻ 0.01) higher in hearts treated with PR-39 compared with vehicle. Fig. 3 . Leukocyte rolling following mesenteric superfusion of vehicle (n ϭ 7), 0.5 U/ml thrombin (n ϭ 6), and 250 g PR-39 ϩ 0.5 U/ml thrombin. Thrombin treatment significantly increased leukocyte rolling at all time points except baseline compared with vehicle. PR-39 administration significantly (P Ͻ 0.05) reduced thrombin stimulation at the 30 and 60 min time points. The significance of this effect was increased at 90 and 120 min (P Ͻ 0.01).
neutrophil sequestration following ischemia and reperfusion. These findings suggest that neutrophil recruitment contributes to cellular necrosis following ischemia and reperfusion. PR-39 has been shown to block reactive oxygen species production in a dose-dependent manner following lung ischemia or exposure to high K ϩ concentrations in rats (2) . Furthermore, studies employing PR-39 prior to rat superior mesenteric artery occlusion and reperfusion observed a significant decrease in neutrophil translocation, reactive oxygen species production, and mesenteric venular protein leakage (18) .
In addition to blunting the development of necrosis following myocardial ischemia and reperfusion, our findings suggest that PR-39 interferes with neutrophilendothelial interaction. We found that PR-39 treatment attenuated chemically induced neutrophil rolling and firm adhesion to the endothelium in the rat mesentery. A previous study (18) demonstrated that PR-39 abrogated neutrophil rolling and firm adherence and prevented transendothelial migration following ischemia and reperfusion of the bowel mesentery. PR-39 has also been shown to downregulate phorbol 12-myristate 13-acetate (PMA)-induced expression of intercellular adhesion molecule-1 (ICAM-1) (18) . It has been suggested that PR-39 may inhibit the action of a transcription factor necessary for the expression of endothelial cell adhesion molecules (ECAM) (4). PR-39 downregulation of ECAM expression could potentially explain our observations of reduced neutrophil-endothelial interaction and attenuated PMN accumulation within the ischemic reperfused myocardium.
Previous studies (21, 32) have suggested that neutrophil recruitment and migration into the ischemic reperfused myocardium mediates the development of cellular necrosis. Neutropenic studies have demonstrated decreases in cellular necrosis following myocardial ischemia and reperfusion (7, 15, 20) . Inhibition of neutrophil-endothelial adhesion, a necessary step in leukocyte sequestering, has been shown to protect in myocardial ischemiareperfusion injury (17) . Monoclonal antibody blockade of endothelial ICAM-1 (35) or its neutrophilic ligand CD11/ CD18 (22) , necessary for leukocyte firm adhesion, yielded decreased myocardial necrosis following ischemia and reperfusion. Studies in mice deficient in P-selectin (26), ICAM-1, and CD18 (27) have shown significant reductions in PMN accumulation and necrosis following myocardial ischemia-reperfusion. The involvement of neutrophils in the development of myocardial ischemia and reperfusion injury seems clear; however, the mechanisms by which activated, sequestered leukocytes damage tissue has yet to be elucidated.
The precise mechanism of action by which PR-39 prevents myocardial ischemia-reperfusion-induced phenomena, however, remains to be determined. In addition to its inhibitory interaction with the p47 phox subunit of NADPH oxidase, PR-39 has been shown to interact with a similar domain within the integrinmediated signaling protein, p130
cas (6) . This finding is important since p130 has been linked to multiple signal transduction pathways as well as cell transformation. Another relevant action of PR-39 is the upregulation of synedacan-1, a heparan sulfate proteoglycan important in wound healing (8) and inhibition of metastatic carcinoma invasion (25) . Interactions with the cytoskeleton could be important in neutrophil transformation during infiltration. A recent study has shown that PR-39 inhibits motility and interacts with actin-based cytoskeletal components in human hepatocellular carcinoma cells (25) . It is possible that PR-39 might inhibit endothelial cell surface expression of adhesion molecules such as P-selectin, E-selectin, and ICAM-1. Elucidation of the mechanism by which PR-39 prevents myocardial ischemia-reperfusion injury is difficult to identify because of its multiple interactions within the cell.
It is important to note the limitations of this study's findings. Myocardial ischemia-reperfusion injury is not completely PMN dependent. Factors such as direct ischemic cell death, Ca 2ϩ overload (24) , membrane swelling, edema (13) , and apoptosis (23) also contribute to myocardial injury. Additionally, the mechanisms that contribute to myocardial ischemia-reperfusion injury in mice and rats may not correspond to those present in the human patient. The use of mice and rats as laboratory models to investigate myocardial ischemia-reperfusion injury in humans has previously been criticized due to differences in physiology between these species and humans. Furthermore, the effectiveness of PR-39 to attenuate myocardial ischemia-reperfusion injury has only been investigated in pretreated animals. Pretreatment is a major limitation since it is difficult to predict the clinical occurrence of myocardial ischemiareperfusion. The effects of the peptide may differ significantly when administered at or following reperfusion.
In conclusion, we found that administration of PR-39 significantly reduced myocardial infarction following ischemia and reperfusion. Furthermore, treatment with PR-39 inhibited neutrophil interaction with the Fig. 4 . Leukocyte adherence in the mesentery following treatment with vehicle (n ϭ 7), 0.5 U/ml thrombin (n ϭ 6), and 250 g PR-39 ϩ 0.5 U/ml thrombin (n ϭ 7). A significant increase in leukocyte adherence was displayed in rats given thrombin at 60, 90, and 120 min compared with vehicle. This effect was significantly (P Ͻ 0.05) reduced with PR-39 treatment at 60 min with P Ͻ 0.01 at 90 and 120 min.
endothelium, resulting in reduced PMN accumulation within the myocardium.
